Our Vision for Advancing Inclusion
Our vision is to create a site network to enable recruitment and retention of underrepresented patient populations to enrich science and enable delivery of Roche Innovation so we can eliminate disparities in outcomes for all patients.
8%
of the global population makes up…
80%
of all clinical research participants, of which
91%
have European ancestry.
6%
of African American women are represented in clinical trials
600%
Increase in disparities-focused publications
2045
Minority-Majority Population
By 2045, minorities will make up the majority of the United States population.
2060
1/3 will live in Africa & India
By 2060, an estimated one-third of the world's total population will live in Africa and India.
Why is AIR important?
Launched in 2020, the Advancing Inclusive Research (AIR) Site Alliance is a partnership between Roche Genentech and selected sites with the aim of prioritizing the inclusion of underrepresented patients in research and ultimately transforming science.
Meet Our Team
Learn more about the AIR Site Alliance team below:
Core Team
